Figure 1.
Overall safety and efficacy of ponatinib based on starting dose. The analysis is a descriptive clinical summary of the data to illustrate the relationship between the efficacy and the AOE rate. TE-AOE, treatment-emergent arterial occlusive events. Reproduced with permission from Cortes et al.13